{"doi":"10.7554/elife.54558","title":"Identifying the immune interactions underlying HLA class I disease associations","abstract":"Variation in the risk and severity of many autoimmune diseases, malignancies and infections is strongly associated with polymorphisms at the HLA class I loci. These genetic associations provide a powerful opportunity for understanding the etiology of human disease. HLA class I associations are often interpreted in the light of ‘protective’ or ‘detrimental’ CD8+ T cell responses which are restricted by the host HLA class I allotype. However, given the diverse receptors which are bound by HLA class I molecules, alternative interpretations are possible. As well as binding T cell receptors on CD8+ T cells, HLA class I molecules are important ligands for inhibitory and activating killer immunoglobulin-like receptors (KIRs) which are found on natural killer cells and some T cells; for the CD94:NKG2 family of receptors also expressed mainly by NK cells and for leukocyte immunoglobulin-like receptors (LILRs) on myeloid cells. The aim of this study is to develop an immunogenetic approach for identifying and quantifying the relative contribution of different receptor-ligand interactions to a given HLA class I disease association and then to use this approach to investigate the immune interactions underlying HLA class I disease associations in three viral infections: Human T cell Leukemia Virus type 1, Human Immunodeficiency Virus type 1 and Hepatitis C Virus as well as in the inflammatory condition Crohn’s disease.","journal":"eLife","year":2020,"id":99078,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":30,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.951,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":488175,"name":"Lies Boelen","orcid":"0000-0003-3786-5545","position":1,"is_corresponding":false},{"id":251313,"name":"James Lee","orcid":"0000-0001-5711-9385","position":2,"is_corresponding":false},{"id":489384,"name":"IAVI Protocol C Investigators","orcid":null,"position":3,"is_corresponding":false},{"id":321061,"name":"Eduard J. Sanders","orcid":"0000-0002-1062-8921","position":4,"is_corresponding":false},{"id":489385,"name":"Omu Anzala","orcid":null,"position":5,"is_corresponding":false},{"id":489386,"name":"Anatoli Kamali","orcid":null,"position":6,"is_corresponding":false},{"id":36860,"name":"Pontiano Kaleebu","orcid":"0000-0001-9706-2977","position":7,"is_corresponding":false},{"id":288614,"name":"Etienne Karita","orcid":"0000-0001-9475-5436","position":8,"is_corresponding":false},{"id":321610,"name":"William Kilembe","orcid":"0000-0002-9012-7325","position":9,"is_corresponding":false},{"id":412590,"name":"Mubiana Inambao","orcid":null,"position":10,"is_corresponding":false},{"id":292864,"name":"Shabir Lakhi","orcid":"0000-0001-5348-7156","position":11,"is_corresponding":false},{"id":321611,"name":"Susan Allen","orcid":"0000-0002-9150-3898","position":12,"is_corresponding":false},{"id":253823,"name":"Eric Hunter","orcid":"0000-0002-4273-8631","position":13,"is_corresponding":false},{"id":488176,"name":"Vinodh Edward","orcid":"0000-0003-3952-4760","position":14,"is_corresponding":false},{"id":413792,"name":"Pat Fast","orcid":"0000-0001-9991-0351","position":15,"is_corresponding":false},{"id":36873,"name":"Matt A. Price","orcid":"0000-0002-2918-1373","position":16,"is_corresponding":false},{"id":322284,"name":"Jill Gilmour","orcid":null,"position":17,"is_corresponding":false},{"id":385018,"name":"Jianming Tang","orcid":"0000-0003-0137-7486","position":18,"is_corresponding":false},{"id":414209,"name":"Chloe L. Thio","orcid":"0000-0002-8851-8319","position":19,"is_corresponding":false},{"id":322410,"name":"Jacquie Astemborski","orcid":"0000-0002-2722-0922","position":20,"is_corresponding":false},{"id":240255,"name":"Gregory D. Kirk","orcid":"0000-0002-7829-1405","position":21,"is_corresponding":false},{"id":488177,"name":"Salim I. Khakoo","orcid":"0000-0002-4057-9091","position":22,"is_corresponding":false},{"id":489387,"name":"Sharyne Donfield","orcid":null,"position":23,"is_corresponding":false},{"id":24059,"name":"James J. Goedert","orcid":"0000-0001-6134-1472","position":24,"is_corresponding":false},{"id":458788,"name":"Becca Asquith","orcid":"0000-0002-5911-3160","position":25,"is_corresponding":false},{"id":488174,"name":"Johnny Debebe","orcid":"0000-0002-6551-5641","position":0,"is_corresponding":true}],"reference_count":87,"raw_metadata":null,"created_at":"2026-07-18T22:37:35.547042Z","pmid":"32238263","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}